Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  HIV Infection

  Free Subscription


Articles published in Antivir Ther

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    January 2008
  1. BENNETT DE , Bertagnolio S, Sutherland D, Gilks CF, et al
    The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Antivir Ther. 2008;13 Suppl 2:1-13.
    PubMed     Related articles    Abstract available


  2. NGUYEN HT , Duc NB, Shrivastava R, Tran TH, et al
    HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
    Antivir Ther. 2008;13 Suppl 2:115-21.
    PubMed     Related articles    Abstract available


  3. SIRIVICHAYAKUL S , Phanuphak P, Pankam T, O-Charoen R, et al
    HIV drug resistance transmission threshold survey in Bangkok, Thailand.
    Antivir Ther. 2008;13 Suppl 2:109-13.
    PubMed     Related articles    Abstract available


  4. PILLAY V , Ledwaba J, Hunt G, Rakgotho M, et al
    Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Antivir Ther. 2008;13 Suppl 2:101-7.
    PubMed     Related articles    Abstract available


  5. MAPHALALA G , Okello V, Mndzebele S, Gwebu P, et al
    Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
    Antivir Ther. 2008;13 Suppl 2:95-100.
    PubMed     Related articles    Abstract available


  6. ABEGAZ WE , Grossman Z, Wolday D, Ram D, et al
    Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.
    Antivir Ther. 2008;13 Suppl 2:89-94.
    PubMed     Related articles    Abstract available


  7. KAMOTO K , Aberle-Grasse J
    Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
    Antivir Ther. 2008;13 Suppl 2:83-7.
    PubMed     Related articles    Abstract available


  8. SOMI GR , Kibuka T, Diallo K, Tuhuma T, et al
    Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
    Antivir Ther. 2008;13 Suppl 2:77-82.
    PubMed     Related articles    Abstract available


  9. HEDT BL , Wadonda-Kabondo N, Makombe S, Harries AD, et al
    Early warning indicators for HIV drug resistance in Malawi.
    Antivir Ther. 2008;13 Suppl 2:69-75.
    PubMed     Related articles    Abstract available


  10. SHAFER RW , Rhee SY, Bennett DE
    Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.
    Antivir Ther. 2008;13 Suppl 2:59-68.
    PubMed     Related articles    Abstract available


  11. BERTAGNOLIO S , Derdelinckx I, Parker M, Fitzgibbon J, et al
    World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Antivir Ther. 2008;13 Suppl 2:49-57.
    PubMed     Related articles    Abstract available


  12. MYATT M , Bennett DE
    A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings.
    Antivir Ther. 2008;13 Suppl 2:37-48.
    PubMed     Related articles    Abstract available


  13. BENNETT DE , Myatt M, Bertagnolio S, Sutherland D, et al
    Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.
    Antivir Ther. 2008;13 Suppl 2:25-36.
    PubMed     Related articles    Abstract available


  14. JORDAN MR , Bennett DE, Bertagnolio S, Gilks CF, et al
    World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Antivir Ther. 2008;13 Suppl 2:15-23.
    PubMed     Related articles    Abstract available


  15. RAUCH A , Gaudieri S, Evison J, Nolan D, et al
    Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
    Antivir Ther. 2008;13:455-60.
    PubMed     Related articles    Abstract available


  16. BOYD MA , Truman M, Hales G, Anderson J, et al
    A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study).
    Antivir Ther. 2008;13:449-53.
    PubMed     Related articles    Abstract available


  17. VISPO E , Barreiro P, Pineda JA, Mira JA, et al
    Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.
    Antivir Ther. 2008;13:429-37.
    PubMed     Related articles    Abstract available


  18. HE Q , Engelson ES, Ionescu G, Glesby MJ, et al
    Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men.
    Antivir Ther. 2008;13:423-8.
    PubMed     Related articles    Abstract available


  19. DEFORCHE K , Cozzi-Lepri A, Theys K, Clotet B, et al
    Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
    Antivir Ther. 2008;13:399-407.
    PubMed     Related articles    Abstract available


  20. DUVAL X , Baron G, Garelik D, Villes V, et al
    Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study.
    Antivir Ther. 2008;13:389-97.
    PubMed     Related articles    Abstract available


  21. ANANWORANICH J , Gayet-Ageron A, Ruxrungtham K, Chetchotisakd P, et al
    Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
    Antivir Ther. 2008;13:375-80.
    PubMed     Related articles    Abstract available


  22. PRICE RW , Parham R, Kroll JL, Wring SA, et al
    Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin.
    Antivir Ther. 2008;13:369-74.
    PubMed     Related articles    Abstract available


  23. MELVIN AJ , Kang M, Hitti J, Livingston E, et al
    Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.
    Antivir Ther. 2008;13:349-55.
    PubMed     Related articles    Abstract available


  24. QUIROS-ROLDAN E , Calabresi A, Lapadula G, Tirelli V, et al
    Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Antivir Ther. 2008;13:341-8.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Boehringer Ingelheim and Pfizer.

Amedeo is a Bernd Sebastian Kamps website.

   Design: